Coya Therapeutics, Inc. (COYA) — research page
US · us-cm-kg/NASDAQ/COYA · as of 2026-11-08
Identity and listing
The issuer is Coya Therapeutics, Inc., listed on NASDAQ under ticker COYA, with ISIN US22407B1089 and LEI not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. The issuer is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Coya Therapeutics, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | COYA | source · 2026-11-08 |
| ISIN | US22407B1089 | source · 2026-10-13 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 43 filings across 23 filing days in the window 2025-11-08 to 2026-11-08. Of these, 11 are directors' dealings, 8 are corporate news, 8 are regulatory filings, 8 are results, 3 are AGM or EGM filings, 3 are prospectuses, and 2 are director changes. The median gap between filing days is 10.0 days, against a NASDAQ median of 6.0 days and a sector median of 6.0 days. Latency from the latest filing to the record date is 25 days, against a NASDAQ median of 5.0 days and a sector median of 4.0 days. The latest filing is corporate news dated 2026-10-14.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 43 | 10 | 25 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-14 | corporate_news | 8-K | 8-K — 8-K (items 8.01) |
| 2026-10-05 | corporate_news | 8-K | 8-K — 8-K (items 8.01) |
| 2026-09-15 | corporate_news | 8-K | 8-K — 8-K (items 8.01) |
| 2026-08-11 | results | 10-Q | 10-Q — 10-Q |
| 2026-08-11 | results | 8-K | 8-K — 8-K (items 2.02,9.01) |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Weaver and Tidwell, L.L.P., located in New York, NY. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting, or name change lines. The domicile change is not on the record, since EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, since the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's own investor-relations page names 6 research houses: BTIG, Chardan, HC Wainwright & CO, Lakestreet, LUCID, and ROTH.
| research house | analyst | source · read date |
|---|---|---|
| BTIG | Thomas Shrader, PhD, CFA | issuer page · 2026-11-11 |
| Chardan | Keay Nakae, CFA | issuer page · 2026-11-11 |
| HC Wainwright & CO | Raghuram Selvaraju, Ph.D | issuer page · 2026-11-11 |
| Lakestreet | Chad Messer, Ph.D. | issuer page · 2026-11-11 |
| LUCID | Elemer Piros, PhD | issuer page · 2026-11-11 |
| ROTH | Boobalan Pachaiyappan | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record seals issuer years 2021, 2022, 2023, 2024, 2025, and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001835022.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/COYA (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://www.sec.gov/Archives/edgar/data/1835022/000119312526107281/coya-20251231.htm (the auditor)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://ir.coyatherapeutics.com/stock-info/analyst-coverage/default.aspx (coverage)
- 10.9
- https://mcp.us-cm-kg.ai/record/NASDAQ/COYA (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US22407B1089"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:bd89132b7af820bc.